Cargando…
Development of a novel senolytic by precise disruption of FOXO4-p53 complex
Autores principales: | Tripathi, Utkarsh, Chaib, Selim, Gerdes, Erin O. Wissler, Hogan, Kelly A., Zhu, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601985/ https://www.ncbi.nlm.nih.gov/pubmed/34768086 http://dx.doi.org/10.1016/j.ebiom.2021.103693 |
Ejemplares similares
-
ORALLY ACTIVE, CLINICALLY TRANSLATABLE SENOLYTICS RESTORE Α-KLOTHO IN MICE AND HUMANS
por: Zhu, Yi, et al.
Publicado: (2022) -
Discovery, development, and future application of senolytics: theories and predictions
por: Wissler Gerdes, Erin O., et al.
Publicado: (2020) -
Paradoxes of senolytics
por: Blagosklonny, Mikhail V.
Publicado: (2018) -
Orally-active, clinically-translatable senolytics restore α-Klotho in mice and humans
por: Zhu, Yi, et al.
Publicado: (2022) -
Molecular modelling of the FOXO4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells
por: Le, Hillary H., et al.
Publicado: (2021)